Tregulatory cells in myocarditis

心肌炎中的调节细胞

基本信息

  • 批准号:
    8452724
  • 负责人:
  • 金额:
    $ 36.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-06-01 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Myocarditis is an inflammation of the heart muscle which often follows microbial infections and evidence indicates that autoimmunity to heart antigens contributes to cardiac injury. Enteroviruses, including coxsackievirus B3 (CVB3), are major etiological agents causing this clinical disease. A mouse model of CVB3 induced myocarditis shares many characteristics of the human disease. Immunity is usually divided into innate (constitutively present or rapidly induced and having either no pathogen specificity or very broad specificity) and adaptive (highly specific responses to inducing pathogen) types. It is clear that the innate immune response can determine both the quality and quantity of the subsequent adaptive immune response. Two innate effectors are: T cells expressing the gamma-delta T cell receptor (34 T cells) and invariant natural killer T (iNKT) cells which express an invariant T cell receptor 1 chain and one of a limited number of 2 TCR chains. In CVB3 induced myocarditis, the V34 subpopulation of 34 T cells is crucial to induction of autoimmunity to cardiac antigens and inflammation in the heart which iNKT cells are protective. Both V34 and iNKT cells react to CD1d, a non-classical major histocompatibility complex class 1-like molecule. CD1d is not only expressed on antigen presenting cells including dendritic cells and macrophage, but is also up-regulated on CD4 T cells in CVB3 infected mice, including a subpopulation of CD4+CD25+FoxP3+ T regulatory cells. Furthermore, the CD1d+ T regulatory cell subpopulation is substantially more immunosuppressive than the CD1d- T regulatory cells from the same infected animal. We provide evidence that 34 T cells in CVB3 infected mice inhibits T regulatory cell responses while iNKT cells promote T regulatory cell response. We hypothesize that 34 T and iNKT cells counter-balance each other and the ultimate ability of CVB3 infected mice to ddevelop autoimmunity and myocarditis depends upon which innate effector dominates. We propose to use two established CVB3 vartiants, H3 and H310A1, which have been cloned and sequenced. H3 virus activates 34 T cells, fails to activate T regulatory cells and induces cardiac autoimmunity. In contrast, H310A1 virus, which differs by a single amino acid from H3 virus, fails to activate 34 T cells, induces T regulatory cells and fails to induce autopimmunity. The Specific Aims will determine: 1) the mechanism(s) by which 34 T and iNKT cells control T regulatory cell activation and how these two effectors counter-balance each other in impacting developing adaptive immunity; and 2) why H3 and H310A1 differ in ability to activate T regulatory cells.
描述(由申请人提供):心肌炎是一种心肌炎症,通常发生在微生物感染之后,有证据表明对心脏抗原的自身免疫有助于心脏损伤。肠病毒,包括柯萨奇B3病毒(CVB3),是引起这种临床疾病的主要病原。CVB3诱导的心肌炎小鼠模型具有人类疾病的许多特征。免疫通常分为先天(组成性存在或快速诱导,没有病原体特异性或非常广泛的特异性)和适应性(对诱导病原体的高度特异性反应)类型。显然,先天免疫反应可以决定随后适应性免疫反应的质量和数量。两种先天效应是:表达γ - δ T细胞受体的T细胞(34个T细胞)和表达不变T细胞受体1链和有限数量的2个TCR链之一的不变自然杀伤T细胞(iNKT)。在CVB3诱导的心肌炎中,34 T细胞的V34亚群对于诱导对心脏抗原和心脏炎症的自身免疫至关重要,而iNKT细胞具有保护作用。V34和iNKT细胞都对CD1d起反应,CD1d是一种非经典的主要组织相容性复合体1类分子。CD1d不仅在树突状细胞和巨噬细胞等抗原提呈细胞上表达,而且在CVB3感染小鼠的CD4 T细胞上也表达上调,包括CD4+CD25+FoxP3+ T调节细胞亚群。此外,CD1d+ T调节细胞亚群比来自同一感染动物的CD1d- T调节细胞具有更强的免疫抑制作用。我们提供的证据表明,CVB3感染小鼠中的34个T细胞抑制T调节性细胞反应,而iNKT细胞促进T调节性细胞反应。我们假设34t和iNKT细胞相互平衡,CVB3感染小鼠发展自身免疫和心肌炎的最终能力取决于哪一种先天效应占主导地位。我们建议使用两个已建立的CVB3变异体H3和H310A1,它们已经被克隆和测序。H3病毒激活34个T细胞,未能激活T调节细胞并诱导心脏自身免疫。相比之下,H310A1病毒与H3病毒只有一个氨基酸的差异,它不能激活34个T细胞,诱导T调节细胞,也不能诱导自身免疫。具体目标将确定:1)34 T细胞和iNKT细胞控制T调节性细胞激活的机制,以及这两种效应物如何相互抵消,影响适应性免疫的发展;2)为什么H3和H310A1激活T调节细胞的能力不同。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sally A Huber其他文献

Sally A Huber的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sally A Huber', 18)}}的其他基金

Tregulatory cells in myocarditis
心肌炎中的调节细胞
  • 批准号:
    8645714
  • 财政年份:
    2011
  • 资助金额:
    $ 36.3万
  • 项目类别:
Tregulatory cells in myocarditis
心肌炎中的调节细胞
  • 批准号:
    8266284
  • 财政年份:
    2011
  • 资助金额:
    $ 36.3万
  • 项目类别:
Tregulatory cells in myocarditis
心肌炎中的调节细胞
  • 批准号:
    8119246
  • 财政年份:
    2011
  • 资助金额:
    $ 36.3万
  • 项目类别:
Innate Immunity in Myocarditis
心肌炎的先天免疫
  • 批准号:
    7658608
  • 财政年份:
    2009
  • 资助金额:
    $ 36.3万
  • 项目类别:
Innate Immunity in Myocarditis
心肌炎的先天免疫
  • 批准号:
    7780450
  • 财政年份:
    2009
  • 资助金额:
    $ 36.3万
  • 项目类别:
T reg Cells in Myocarditis
心肌炎中的 T reg 细胞
  • 批准号:
    7341114
  • 财政年份:
    2007
  • 资助金额:
    $ 36.3万
  • 项目类别:
T reg Cells in Myocarditis
心肌炎中的 T reg 细胞
  • 批准号:
    7760619
  • 财政年份:
    2007
  • 资助金额:
    $ 36.3万
  • 项目类别:
T reg Cells in Myocarditis
心肌炎中的 T reg 细胞
  • 批准号:
    7173106
  • 财政年份:
    2007
  • 资助金额:
    $ 36.3万
  • 项目类别:
T reg Cells in Myocarditis
心肌炎中的 T reg 细胞
  • 批准号:
    7564131
  • 财政年份:
    2007
  • 资助金额:
    $ 36.3万
  • 项目类别:
Sex in Myocarditis
心肌炎中的性行为
  • 批准号:
    6911795
  • 财政年份:
    2005
  • 资助金额:
    $ 36.3万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 36.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 36.3万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 36.3万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 36.3万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 36.3万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 36.3万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 36.3万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 36.3万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 36.3万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 36.3万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了